Status:
UNKNOWN
Role Of Lactobacillus Reuteri DSM 17938 In The Non-Complicated Diverticular Disease
Lead Sponsor:
Casa Sollievo della Sofferenza IRCCS
Collaborating Sponsors:
Careggi Hospital
Conditions:
Diverticulosis
Diverticulitis
Eligibility:
All Genders
18-80 years
Phase:
PHASE3
Brief Summary
The aim of this study is to evaluate the effectiveness and the tolerability of the Lactobacillus reuteri in the control of the diverticular disease symptoms and in the prevention of acute diverticulit...
Detailed Description
The gastrointestinal apparatus hosts a bacterial population that quantifies to around 1011 microorganisms per gram of content with more than 400 different species. Its principal functions are: metabol...
Eligibility Criteria
Inclusion
- Adult patients affected by symptomatic diverticulosis
- Informed consent obtained and signed.
- Expected compliance
Exclusion
- Patients supplemented with other probiotics
- Patients treated with antibiotics
- Patients affected by hearth failure, renal failure, neoplasia
Key Trial Info
Start Date :
February 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2013
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT01168154
Start Date
February 1 2009
End Date
December 1 2013
Last Update
June 28 2011
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Careggi Hospital
Florence, Italy, 50141
2
Casa Sollievo della Sofferenza Hospital - IRCCS
San Giovanni Rotondo, Italy, 71013